Guiyang New Pharmaceutical Co., Ltd. Audit Opinion on the Second Extraordinary Meeting of the Eighth Board of Directors
Guiyang New Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the Second Extraordinary Meeting of the Eighth Board of Directors on March 16, 2026, in a face-to-face format. Three independent directors were entitled to attend, and three independent directors actually attended and voted. The convening of the meeting complied with the relevant provisions of the "Company Law," the "Administrative Measures for Independent Directors of Listed Companies," and other laws, regulations, normative documents, and the "Articles of Association."